TP53 and Alzheimer disease: In conclusion, through the integration of GWAS results on U-p53 as a reliable early-stage AD biomarker with brain single-cell RNA-seq and multimodal datasets, we have identified several significant genes associated with blood U-p53 and potentially with AD, particularly among non-demented subjects.